Rethinking Innovation: Why Biotech is Thriving in LA


Hybrid event: in-person at MannKind Corporation (Westlake Village) or virtual on Zoom  
Thursday, December 01, 2022 5:00 PM - 7:30 PM   Add to Calendar Pacific Standard Time

Innovation and resilience are key to successful growth for LA biotechnology companies. Two years of pandemic uncertainty and geopolitical unrest have changed dynamics across all industries. LA Biotechnology companies are successfully navigating these uncharted waters, and rapid innovation is cause for enthusiasm. More than 6,000 drugs are currently in active development, including 800 next-gen biotherapeutics, with emerging biotechs leading the charge. Trends in innovation extend beyond novel mechanisms and platforms; companies are prioritizing ESG and the industry is rethinking clinical trial design to ensure diverse, representative recruitment and to get drugs to market faster. Investors are optimistic that biotech will outperform the broader market, and LA’s thriving biotech scene is well-positioned to spearhead this continued progress. Join the HBA LA and leaders from small biotechs in the area to reflect on 2022 and share their outlooks and optimism for the future of the industry in our region.

HBA Los Angeles presents

Rethinking Innovation: Why Biotech is Thriving in LA


Date and time
Thursday, 01 December
05:00PM - 07:30PM PST
Location
Hybrid event: in-person at MannKind Corporation (Westlake Village) or virtual on Zoom

Event Contact
Elizabeth Watt
Competencies
12. Continues to learn, grow and transform
Event Sponsor

IMPORTANT: The Healthcare Businesswomen's Association (HBA) requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement prior to taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.

By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act in a reasonable and prudent manner under the circumstances. I further understand that any HBA volunteers participating in the activity will be acting in an individual capacity only and will not represent the HBA. As a condition to my participation in the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.


Innovation and resilience are key to successful growth for LA biotechnology companies. Two years of pandemic uncertainty and geopolitical unrest have changed dynamics across all industries. LA Biotechnology companies are successfully navigating these uncharted waters, and rapid innovation is cause for enthusiasm. More than 6,000 drugs are currently in active development, including 800 next-gen biotherapeutics, with emerging biotechs leading the charge. Trends in innovation extend beyond novel mechanisms and platforms; companies are prioritizing ESG and the industry is rethinking clinical trial design to ensure diverse, representative recruitment and to get drugs to market faster. Investors are optimistic that biotech will outperform the broader market, and LA’s thriving biotech scene is well-positioned to spearhead this continued progress. Join the HBA LA and leaders from small biotechs in the area to reflect on 2022 and share their outlooks and optimism for the future of the industry in our region.

Additional Information 
Hybrid event: in-person at MannKind Corporation (Westlake Village) or virtual on Zoom

Agenda 
5:00-5:30pm: Check-in
5:30-6:30pm: Panel discussion
6:30-7:00pm: Q&A
7:00-7:30pm: Networking

Registration information
Event is open to: HBA Members and Nonmembers
Onsite (walk -in) registration: Is Allowed

Onsite registration is not recommended. If you choose to register onsite, please arrive at least fifteen minutes early and be prepared to use your smartphone / mobile device to complete the transaction. Only credit card payments are accepted. Nonmembers are advised to create an HBA profile prior to arriving.

Featured Speakers

Michael  Castagna
Chief Executive Officer
MannKind Corporation
David  Lucas
Chief Operating Officer
A2 Biotherapeutics
Helen  McBride
SVP Translational Sciences
TORL Biotherapeutics
Swati  Tole
Chief Medical Officer
Capsida Biotherapeutics, Inc
Learning Objectives

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: In-Person Registration

 Member$35.00
 Member - Euro€31.00
 Non-Member$45.00
 Non-Member - Euro€40.00
Collapse group

Registration: Sponsor Employee Registration (In-Person)

 Member$35.00
 Member - Euro€31.00
 Non-Member$35.00
 Non-Member - Euro€31.00
Collapse group

Registration: Virtual Registration (By Zoom)

 Member$10.00
 Member - Euro€8.00
 Non-Member$20.00
 Non-Member - Euro€17.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.